---
layout: post
title: "日本暂停阿斯利康新冠疫苗临床试验"
date: 2020-09-09T11:54:58.000Z
author: 法广
from: http://www.rfi.fr//cn/%E4%BA%9A%E6%B4%B2/20200909-%E6%97%A5%E6%9C%AC%E6%9A%82%E5%81%9C%E9%98%BF%E6%96%AF%E5%88%A9%E5%BA%B7%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E4%B8%B4%E5%BA%8A%E8%AF%95%E9%AA%8C
tags: [ 法广 ]
categories: [ 法广 ]
---
<!--1599652498000-->
[日本暂停阿斯利康新冠疫苗临床试验](http://www.rfi.fr//cn/%E4%BA%9A%E6%B4%B2/20200909-%E6%97%A5%E6%9C%AC%E6%9A%82%E5%81%9C%E9%98%BF%E6%96%AF%E5%88%A9%E5%BA%B7%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E4%B8%B4%E5%BA%8A%E8%AF%95%E9%AA%8C)
------

<div>
<div>09/09/2020 - 12:45</div><img src="https://s.rfi.fr/media/display/4fbce2ce-9ba6-11ea-a6c5-005056bf18d4/w:310/p:16x9/cover-r4x3w1000-5ec6517fb7ce1-coronavirus-resultats-prometteurs-pour-un-vaccin.jpg"><p><strong>英国阿斯利康公司（AstraZeneca）9月8日暂停了其冠状病毒疫苗临床试验，其原因是新型冠状病毒疫苗在临床试验中疑似发生副作用，一名志愿者患有无法解释的疾病，关于这一问题，该公司日本法人的公关负责人9日表示将叫停在日本的临床试验。</strong></p><div class="t-content__body u-clearfix"><p><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">阿斯利康的公关方面表示：</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">为</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">了使独立委</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">员</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">会的</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">对</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">安全数据</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">进</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">行</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">调查</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">，疫苗</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">临</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">床</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">试验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">自</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">动</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">停止。</span></span></span></span></p><p><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">阿斯利康的公关方面表示：在</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">发现</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">于</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">临</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">床</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">试验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">中</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">发</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">生原因不明的症状的可能性的</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">时</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">候，停止</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">试验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">是</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">为</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">了保</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">证试验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">的</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">彻</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">底的安全性所制定的措施，</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">现</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">在正在</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">进</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">行</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">调查</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">。</span></span></span></span></p><p><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">暂时</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">停止</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">临</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">床</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">试验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">的，是牛津大学和阿斯利康共同开</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">发</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">的疫苗</span></span><span style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">“</span></span><span style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">AZD1222”。根据阿斯利康的消息，在接种后</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">这</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">种疫苗后，</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">怀</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">疑在</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">临</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">床</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">试验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">的参加者中出</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">现严</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">重的副作用反</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">应</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">。</span></span></span></span></p><p><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">日本厚生</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">劳动</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">大臣加藤</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">胜</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">信</span></span><span style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">8月7日表示，英国制</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">药</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">巨</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">头</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">阿斯利康正在研</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">发</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">的新型冠状病毒感染症疫苗，日本政府基本与</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">该</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">公司达成了</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">协议</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">，若疫苗能投入</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">实</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">用，从明年起将接受</span></span><span style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">1.2</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">亿</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">次份的供</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">应</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">。</span></span></span></span></p><p><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">日本原</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">计</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">划到明年</span></span><span style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">3月底</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">为</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">止</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">接受</span></span><span style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">3000万次份。加藤向媒体表示：“将朝着最</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">终签约</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">的方向迅速推</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">进</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">磋商，</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">还</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">会</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">继续</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">与其他疫苗厂家开展磋商。</span></span><span style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">”那</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">时</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">日本政府已</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">经</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">就接受</span></span><span style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">6000万人份的疫苗供</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">应</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">，与美国制</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">药</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">巨</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">头辉</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">瑞基本达成</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">协议</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">。</span></span></span></span></p><p><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">日本从上个月末</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">刚刚</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">开始</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">对这</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">种疫苗</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">进</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">行</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">临</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">床</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">试验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">，阿斯利康表示：包括日本在内，都</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">暂</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">停</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">临</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">床</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">试验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">，以</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"Microsoft YaHei",sans-serif">检验</span></span><span lang="ZH-CN" style="font-size:10.0pt"><span style="font-family:"MS PGothic",sans-serif">其安全性。</span></span></p><div class="o-self-promo o-self-promo--nl o-self-promo--hidden" data-selfpromo-newsletter></div><div class="o-self-promo o-self-promo--app o-self-promo--hidden" data-selfpromo-app></div></div>
</div>
